Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125833671 | 12583367 | 1 | I | 20160720 | 20160722 | 20160722 | EXP | PHHY2016CA100485 | NOVARTIS | 0.00 | Y | 0.00000 | 20160722 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125833671 | 12583367 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | UNK | U | 21588 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125833671 | 12583367 | 1 | Chronic myeloid leukaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125833671 | 12583367 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125833671 | 12583367 | Malaise | |
125833671 | 12583367 | Renal cell carcinoma | |
125833671 | 12583367 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |